1. Center for Disease Control and Prevention, US Department of Health and Human Services. Ovarian cancer. Inside knowledge about gynecologic cancer 99-9124. 2019. https://www.cdc.gov/cancer/ovarian/pdf/ovarian_facts.pdf. Accessed June 2019.
2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.
3. National Cancer Institute. BRCA mutations: cancer risk and genetic testing. 2018. https://www.cancer.gov/about-cancer/causes-prevention/genetics/brca-fact-sheet#how-much-does-having-a-brca1-or-brca2-gene-mutation-increase-a-womans-risk-of-breast-and-ovarian-cancer. Accessed July 2019.
4. O’Connor MJ. Targeting the DNA damage response in cancer. Mol Cell. 2015;60(4):547–60.
5. US FDA. FDA approves olaparib tablets for maintenance treatment in ovarian cancer. 2017. https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-olaparib-tablets-maintenance-treatment-ovarian-cancer. Accessed June 2019.